ICAP Ocean Tomo Announces Sale of Fundamental Nanotech and Display Technology Patents

ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L) and the world's premier patent auction firm, announces the sale of fundamental nanotech and display patents from renowned inventor Till Keesman.

Consisting of three issued US patents and ten related applications and foreign counterparts, this opportunity is one of the most valuable display technology portfolios to come onto the market in recent years.

At the core of the portfolio, US patents 5,773,921, RE38,561, and RE38,223 relate to field emission display (FED), the underlying technology behind next-generation flat panel displays.  Together, the patents have been cited by major corporations working in the display field, including Samsung, Hitachi, Sony, Canon, Sharp, Toshiba, Motorola, IBM, and Alcatel Lucent – the '921 patent alone has over 120 forward citations.  In 2004, patent RE38,223 was listed by the Intellectual Property & Technology Law Journal as one of the top ten Nanotech Patents in the world.

"Display technologies are continuing to evolve over time, and FED is one of the core technologies that will take over the market in the coming years," commented Dean Becker, CEO of ICAP Ocean Tomo. "This portfolio contains patents that are essential to companies looking to utilize this technology in the market."

Source: http://icapoceantomo.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.